[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Kidney Stone Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Type

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

4.2       Calcium Oxalate Stones

4.3       Uric Acid

4.4       Struvite Kidney Stones

4.5       Cystine Stones

4.6       Calcium Phosphate Stones

5.         By Treatment Type   

5.1       Introduction

5.1.1    Market Size & Forecast (Value)

5.2       Medications

5.3       Extracorporeal Shock Wave Lithotripsy

5.4       Ureteroscopy

5.5       Percutaneous Nephrolithotomy

6          By Regional Overview          

6.1       Introduction 

6.1.1    Market Size & Forecast (Value)         

6.2       America         

6.2.1    North America           

6.2.1.1 U.S.     

6.2.1.1.1          By Type          

6.2.1.1.2          By Treatment Type    

6.2.1.2 Canada           

6.2.1.2.1          By Type          

6.2.1.2.2          By Treatment Type    

6.2.1.3 Mexico           

6.2.1.3.1          By Type          

6.2.1.3.2          By Treatment Type    

6.2.2    South America

6.2.2.1            By Type

6.2.2.2            By Treatment Type

6.3       Europe           

6.3.1    Market Size & Forecast (Value)         

6.3.2    Western Europe

6.3.2.1      Germany    

6.3.2.1.1          By Type          

8.3.2.1.2           By Treatment Type    

6.3.2.2      France        

6.3.2.2.1          By Type          

6.3.2.2.2           By Treatment Type    

6.3.2.3      U.K 

6.3.2.3.1          By Type          

6.3.2.3.2          By Treatment Type    

6.3.2.4      Italy

6.3.2.4.1          By Type          

6.3.2.4.2          By Treatment Type    

6.3.2.5      Spain          

6.3.2.5.1          By Type          

6.3.2.5.2          By Treatment Type    

6.3.2.6      Rest of Western Europe    

6.3.2.6.1          By Type

6.3.2.6.2          By Treatment Type

6.3.3    Eastern Europe

6.4       Asia Pacific    

6.4.1    Market Size & Forecast (Value)         

6.4.2    China  

6.4.2.1              By Type

6.4.2.2              By Treatment Type

6.4.3    India

6.4.3.1              By Type

6.4.3.2              By Treatment Type

6.4.4    Japan  

6.4.4.1              By Type          

6.4.4.2              By Treatment Type    

6.4.5    South Korea    

6.4.5.1              By Type          

6.4.5.2              By Treatment Type    

6.4.6    Australia         

6.4.6.1             By Type          

6.4.6.2             By Treatment Type    

6.4.      Rest of Asia-Pacific    

6.4.7.1              By Type         

6.4.6.2              By Treatment Type    

6.5       Middle East & Africa

6.5.1    Market Size & Forecast (Value)         

6.5.2    The Middle East

6.5.2.1      Saudi Arab

6.5.2.1.1          By Type          

6.5.2.1.2          By Treatment Type    

6.5.2.2      UAE

6.5.2.2.1          By Type         

6.5.2.2.2          By Treatment Type    

6.5.2.3      Qatar

6.5.2.3.1          By Type         

6.5.2.3.2          By Treatment Type    

6.5.2.4      Rest of Middle East

6.5.2.4.1          By Type

6.5.2.4 2          By Treatment Type

6.6       Africa

6.6.1         By Type      

6.6.2         By Treatment Type

7.         Company Profile                  

7.1       Boston Scientific Corporation

7.1.1    Company Overview   

7.1.2    Financial Performance          

7.1.3    Recent Developments

7.1.4    Product Portfolio        

7.2       Convergent Laser Technologies        

7.2.1    Company Overview   

7.2.2    Financial Performance          

7.2.3    Recent Developments

7.2.4    Product Portfolio        

7.3       DirexGroup

7.3.1    Company Overview   

7.3.2    Financial Performance          

7.3.3    Recent Developments

7.3.4    Product Portfolio        

7.4       Siemens Healthcare GmbH

7.4.1    Company Overview   

7.4.2    Financial Performance          

7.4.3    Recent Developments

7.4.4    Product Portfolio        

7.5       C.R. Bard Inc

7.5.1    Company Overview   

7.5.2    Financial Performance          

7.5.3    Recent Developments

7.5.4    Product Portfolio        

7.6       Cook Medical Inc       

7.6.1    Company Overview   

7.6.2    Financial Performance          

7.6.3    Recent Developments

7.6.4    Product Portfolio        

7.7       Dornier MedTech GmbH

7.7.1    Company Overview   

7.7.2    Financial Performance          

7.7.3    Recent Developments

7.7.4    Product Portfolio        

7.8       Richard Wolf Medical Instruments Corporation

7.8.1    Company Overview   

7.8.2    Financial Performance          

7.8.3    Recent Developments

7.8.4    Product Portfolio        

7.9       Olympus Corporation

7.9.1    Company Overview   

7.9.2    Financial Performance          

7.9.3    Recent Developments

7.9.4    Product Portfolio        

7.10     Stryker Corporation

7.10.1  Company Overview   

7.10.2  Financial Performance          

7.10.3  Recent Developments

7.10.4  Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports